Fanconi's anemia: Current concepts

Blanche P. Alter

Research output: Contribution to journalArticle

Abstract

Fanconi's anemia is an autosomal recessive disorder with a high incidence (>90%) of aplastic anemia and a premalignant component with a >10% risk of leukemia or solid tumors. The diagnosis of Fanconi's anemia depends on increased chromosomal breakage in lymphocytes following treatment with a DNA cross-linking agent; patients have been identified who are clinically well and whose physical appearance is normal. Although bone marrow or cord blood transplants can be curative, treatment for the aplastic anemia usually depends on androgens. Close to 20 patients with Fanconi's anemia have delivered normal babies, and the mothers' hematologic status was not significantly adversely affected by the pregnancy. A few patients have clonal cytogenetic abnormalities in their bone marrow that do not necessarily indicate leukemic transformation, but further follow-up is important. Studies of in vitro erythropoiesis indicate a correlation between the clinical hematologic status and the presence of erythroid progenitors in the blood or bone marrow. Certain hematopoietic growth factors do increase growth in vitro, suggesting that new types of therapy may become available. Not every patient has a poor prognosis. There are now many adults with Fanconi's anemia, some with families of their own.

Original languageEnglish (US)
Pages (from-to)170-176
Number of pages7
JournalJournal of Pediatric Hematology/Oncology
Volume14
Issue number2
StatePublished - 1992
Externally publishedYes

Fingerprint

Fanconi Anemia
Aplastic Anemia
Bone Marrow
Chromosome Breakage
Erythropoiesis
Fetal Blood
Chromosome Aberrations
Androgens
Intercellular Signaling Peptides and Proteins
Leukemia
Therapeutics
Mothers
Lymphocytes
Transplants
Pregnancy
DNA
Incidence
Growth
Neoplasms
In Vitro Techniques

Keywords

  • Aplastic anemia
  • Bone marrow
  • Fanconi's anemia
  • Leukemia
  • Pregnancy
  • Preleukemia

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Pediatrics, Perinatology, and Child Health

Cite this

Fanconi's anemia : Current concepts. / Alter, Blanche P.

In: Journal of Pediatric Hematology/Oncology, Vol. 14, No. 2, 1992, p. 170-176.

Research output: Contribution to journalArticle

Alter, BP 1992, 'Fanconi's anemia: Current concepts', Journal of Pediatric Hematology/Oncology, vol. 14, no. 2, pp. 170-176.
Alter, Blanche P. / Fanconi's anemia : Current concepts. In: Journal of Pediatric Hematology/Oncology. 1992 ; Vol. 14, No. 2. pp. 170-176.
@article{c9c117c71d9d461b91bd034ad465947d,
title = "Fanconi's anemia: Current concepts",
abstract = "Fanconi's anemia is an autosomal recessive disorder with a high incidence (>90{\%}) of aplastic anemia and a premalignant component with a >10{\%} risk of leukemia or solid tumors. The diagnosis of Fanconi's anemia depends on increased chromosomal breakage in lymphocytes following treatment with a DNA cross-linking agent; patients have been identified who are clinically well and whose physical appearance is normal. Although bone marrow or cord blood transplants can be curative, treatment for the aplastic anemia usually depends on androgens. Close to 20 patients with Fanconi's anemia have delivered normal babies, and the mothers' hematologic status was not significantly adversely affected by the pregnancy. A few patients have clonal cytogenetic abnormalities in their bone marrow that do not necessarily indicate leukemic transformation, but further follow-up is important. Studies of in vitro erythropoiesis indicate a correlation between the clinical hematologic status and the presence of erythroid progenitors in the blood or bone marrow. Certain hematopoietic growth factors do increase growth in vitro, suggesting that new types of therapy may become available. Not every patient has a poor prognosis. There are now many adults with Fanconi's anemia, some with families of their own.",
keywords = "Aplastic anemia, Bone marrow, Fanconi's anemia, Leukemia, Pregnancy, Preleukemia",
author = "Alter, {Blanche P.}",
year = "1992",
language = "English (US)",
volume = "14",
pages = "170--176",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Fanconi's anemia

T2 - Current concepts

AU - Alter, Blanche P.

PY - 1992

Y1 - 1992

N2 - Fanconi's anemia is an autosomal recessive disorder with a high incidence (>90%) of aplastic anemia and a premalignant component with a >10% risk of leukemia or solid tumors. The diagnosis of Fanconi's anemia depends on increased chromosomal breakage in lymphocytes following treatment with a DNA cross-linking agent; patients have been identified who are clinically well and whose physical appearance is normal. Although bone marrow or cord blood transplants can be curative, treatment for the aplastic anemia usually depends on androgens. Close to 20 patients with Fanconi's anemia have delivered normal babies, and the mothers' hematologic status was not significantly adversely affected by the pregnancy. A few patients have clonal cytogenetic abnormalities in their bone marrow that do not necessarily indicate leukemic transformation, but further follow-up is important. Studies of in vitro erythropoiesis indicate a correlation between the clinical hematologic status and the presence of erythroid progenitors in the blood or bone marrow. Certain hematopoietic growth factors do increase growth in vitro, suggesting that new types of therapy may become available. Not every patient has a poor prognosis. There are now many adults with Fanconi's anemia, some with families of their own.

AB - Fanconi's anemia is an autosomal recessive disorder with a high incidence (>90%) of aplastic anemia and a premalignant component with a >10% risk of leukemia or solid tumors. The diagnosis of Fanconi's anemia depends on increased chromosomal breakage in lymphocytes following treatment with a DNA cross-linking agent; patients have been identified who are clinically well and whose physical appearance is normal. Although bone marrow or cord blood transplants can be curative, treatment for the aplastic anemia usually depends on androgens. Close to 20 patients with Fanconi's anemia have delivered normal babies, and the mothers' hematologic status was not significantly adversely affected by the pregnancy. A few patients have clonal cytogenetic abnormalities in their bone marrow that do not necessarily indicate leukemic transformation, but further follow-up is important. Studies of in vitro erythropoiesis indicate a correlation between the clinical hematologic status and the presence of erythroid progenitors in the blood or bone marrow. Certain hematopoietic growth factors do increase growth in vitro, suggesting that new types of therapy may become available. Not every patient has a poor prognosis. There are now many adults with Fanconi's anemia, some with families of their own.

KW - Aplastic anemia

KW - Bone marrow

KW - Fanconi's anemia

KW - Leukemia

KW - Pregnancy

KW - Preleukemia

UR - http://www.scopus.com/inward/record.url?scp=0026607986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026607986&partnerID=8YFLogxK

M3 - Article

C2 - 1530123

AN - SCOPUS:0026607986

VL - 14

SP - 170

EP - 176

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 2

ER -